Clinical Trial Update: THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health [Phase 4]

View source ↗

Summary

Phase 4 THRIVE study evaluating how nicotine-containing oral pouches affect public health; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco-related Carcinoma

Drugs mentioned

• Oral nicotine pouches (nicotine pouch)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Tobacco-Related Carcinoma | Phase 4 | Status: NOT_YET_RECRUITING